Clinical Study of Intravesical Pirarubicin Instillation to Prevent the Postoperative Recurrence of Superficial Bladder Cancer

秦军,袁建林,刘贺亮,邵晨,秦卫军,秦荣良,王禾
DOI: https://doi.org/10.3969/j.issn.1672-4992.2008.06.049
2008-01-01
Journal of Modern Oncology
Abstract:Objective:The therapeutic effect and safety of intravesical pirarubicin(THP) instillation to prevent the postoperarive recurrence of superficial bladder cancer were explored.Methods:Total of 108 patients of superficial bladder cancer underwent TURBt or partial cystectomy.One week postoperation,30 mg THP dissolved in 40 ml of 5%glucose solution were weekly intravesical instillated,and retained in bladder for 30-60 minutes for eight weeks.Subsequently,intravesical instillations were done once a month for ten months.The patients had been followed up for one and a half years to eight and half years.Results:No systemic adverse drug reaction was found in 108 patients,except minor bladder irritation occurred in 15 cases.Tumor recurrence occurred in 18 cases,with recurrence rate of 16.67%.Conclusion:Intravesical instillation of THP is effective method to prevent the postoperative recurrence of superficial baldder cancer,which is safe with precise curative effect and less side effect.Long-term medical effects needs to be further studied.
What problem does this paper attempt to address?